<?xml version="1.0" encoding="UTF-8"?>
<p>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that selectively affects motor neurons. The typical symptomatic hallmark involves muscle weakness and wasting, cramps, poor reflexes, twitching, and speech problems. The worldwide incidence is estimated to be 2–3 per 100,000, and most patients have first symptoms in their sixth and seventh decades [
 <xref rid="B1-ijms-19-01312" ref-type="bibr">1</xref>]. The majority of patients diagnosed with ALS are classified as having sporadic disease, whereas 5–10% have a positive family history [
 <xref rid="B2-ijms-19-01312" ref-type="bibr">2</xref>]. To date, several genes and loci of major effect have been identified, and among the known genes, mutations in SOD1 (superoxide dismutase 1) account for 20% of familial ALS [
 <xref rid="B1-ijms-19-01312" ref-type="bibr">1</xref>].
</p>
